Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | GMNN | O75496 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | CETP | P11597 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.40 |
| ▸ | CCR6 | P51684 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2417464 | 1.00 | FAAH (0.52) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL2416670 | 1.00 | FAAH (0.52) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL31538342 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL31538316 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL2415402 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL2415396 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL2417265 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL31538386 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL31538312 | 0.98 | FAAH (0.55) | FAAHTRPV1TSHRALDH1A1LTB4R | |
| SCHEMBL31538390 | 0.94 | TSHR (0.46) | FAAHTRPV1TSHRALDH1A1LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399399-B2 | compared with their structural isomer 2-methyl-4-dodecanal, are characterized by an odor threshold concentration which is up to 64 times lower | GIVAUDAN SA (CH) | 2013-03-19 | — | — | US | disclosed |
| EP-1743880-B1 | 3- and 4-methyl-dodecenal and their use in fragrance or flavour compositions | GIVAUDAN SA (CH) | 2011-09-28 | — | — | EP | disclosed |
| US-20080248177-A1 | 3- and 4-Methyl Dodecenal and their Use in Fragrance and Flavour Compositions | GIVAUDAN SA (CH) | 2008-10-09 | — | — | US | disclosed |
| CN-101198577-A | 3- and 4-methyl-dodecenal and their use in fragrance or flavour compositions | GIVAUDAN SA (CH) | 2008-06-11 | — | — | CN | disclosed |
| EP-1743880-A1 | 3- and 4-methyl-dodecenal and their use in fragrance or flavour compositions | Givaudan S.A. (CH) | 2007-01-17 | — | — | EP | disclosed |
| WO-2006133591-A1 | 3-AND 4-METHYL-DODECENAL AND THEIR USE IN FRAGRANCE OF FLAVOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080248177-A1 | 3- and 4-Methyl Dodecenal and their Use in Fragrance and Flavour Compositions | COXFA4, FADS2, DHCR24 | FAAH 107/4885TRPV1 156/4885TSHR 4755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.